BCL2 and autoimmune disease: As in other autoimmune diseases, MSCs from patients with SLE exhibited increased frequencies of apoptosis, as evidenced by the downregulation of Bcl-2 and upregulation of Bax, and higher intracellular ROS levels than those in normal MSCs [18].